BIOGEN INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biogen Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2024.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was -$77.5M, a 36.9% decline year-over-year.
  • Biogen Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was -$302M, a 9.88% decline year-over-year.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2024 was -$302M, a 9.88% decline from 2023.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2023 was -$274M, a 4.14% decline from 2022.
  • Biogen Inc. annual Share-based Payment Arrangement, Expense for 2022 was -$264M, a 6.85% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.